May 10, 2013
Sigma-Tau Pharmaceuticals Launches CYSTARAN(TM) for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis
Read More
October 4, 2012
Sigma-Tau Pharmaceuticals, Inc. Receives FDA Approval of CYSTARAN™ (Cysteamine Ophthalmic Solution)
Read More
X